GARDASIL Vaccine Impact in Population Study.
Phase of Trial: Phase IV
Latest Information Update: 29 Apr 2017
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Female genital diseases; Human papillomavirus infections; Vulvovaginal cancer
- Focus Therapeutic Use
- Acronyms VIP
- Sponsors Merck Sharp & Dohme
- 12 Dec 2015 Change in Time Frame after Gardasil licensure:- changed from 2011-2012 to 2007-2011. Patient ages also specifically mentioned in the timepoints as per ClinicalTrials.gov record.
- 01 Jan 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.
- 06 Mar 2010 New trial record